Clinical Trial Update: Pre-operative Treatment With Erythropoietin and Iron Supplement in Cardiac Surgery [Phase 4]

View source ↗

Summary

A Phase 4 trial evaluating pre-operative erythropoietin and iron supplementation in cardiac surgery was terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Heart Disease
• Iron Deficiency Anemia

Drugs mentioned

• Erythropoietin (erythropoietin)
• Ferrous sulfate (ferrous sulfate)

Snippet

Sponsor: Catharina Ziekenhuis Eindhoven | Conditions: Heart; Dysfunction Postoperative, Cardiac Surgery, Anemia, Iron-Deficiency | Phase 4 | Status: TERMINATED